bpc-157 safety human clinical data and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded This doesn't mean BPC-157 is
Description
Unknown long-term profile: Long-term human safety data is limited
Moreover, cancer cells expressing mutant p53 exhibit increased sensitivity to mTOR inhibition compared to cancer cells with WT p53 [81]

RetailleauKDupratFArhatteMRanadeSSPeyronnetRMartinsJRet al

Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S
